RianCorp LTD

RianCorp, LLC

Low Level Laser Device Manufacturer

Based in Australia, RianCorp focuses on medical laser products and manufactures devices for low level laser therapy (LLLT).

Their LTU-904 low level laser device offers a painless and effective solution for the treatment of post-mastectomy lymphedema. The LTU-904 laser is the only laser device that has been cleared by the FDA for lymphedema treatment after breast cancer.

This lightweight, handheld, infra-red, low level laser operates at a wavelength of 904 nanometers. Classified by the FDA as a Class 1 laser, protective eyewear isn’t required for patients or therapists when the laser is in use.

In a randomized, double-blind clinical trial, RianCorp tested the effects of LLLT on lymphedema – the clinical trial was the first of its kind in the world!

The study showed that the benefits of laser therapy treatment for post-mastectomy lymphedema include:

• reduced arm volume, and extra-cellular fluid in the arm
• less inflammation and swelling
• shorter recovery times
• reduced scar tissue and scarring